How should continental vaccine manufacturers handle complex dynamics of supply and demand? ANALYSIS | The African Union has ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

The agreement, worth $4.3 million, is the first to be announced as part of CEPI’s call in January 2022 for proposals aimed at improving thermostability of a variety of new vaccine platforms ...

There are however still a lot of areas for improvement, he added, including thermostability – which has meant that first-generation COVID-19 vaccines have had to be stored at very low ...

Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic ...

You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...